Filing Details
- Accession Number:
- 0000899243-17-004753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-21 16:31:53
- Reporting Period:
- 2017-02-17
- Filing Date:
- 2017-02-21
- Accepted Time:
- 2017-02-21 16:31:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1341235 | Aldeyra Therapeutics Inc. | ALDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604458 | Ben Bronstein | C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-17 | 4,444 | $4.50 | 16,944 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017.